PL3685167T3 - Sposób diagnozy i prognozy chorób neurodegeneracyjnych i neurozapalnych - Google Patents

Sposób diagnozy i prognozy chorób neurodegeneracyjnych i neurozapalnych

Info

Publication number
PL3685167T3
PL3685167T3 PL18789217T PL18789217T PL3685167T3 PL 3685167 T3 PL3685167 T3 PL 3685167T3 PL 18789217 T PL18789217 T PL 18789217T PL 18789217 T PL18789217 T PL 18789217T PL 3685167 T3 PL3685167 T3 PL 3685167T3
Authority
PL
Poland
Prior art keywords
prognosis
neurodegenerative
diagnosis
neuroinflammatory diseases
neuroinflammatory
Prior art date
Application number
PL18789217T
Other languages
English (en)
Inventor
Armando CHIERCHIA
Fabio BIANCO
Original Assignee
Braindtech S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braindtech S.P.A. filed Critical Braindtech S.P.A.
Publication of PL3685167T3 publication Critical patent/PL3685167T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL18789217T 2017-09-21 2018-09-20 Sposób diagnozy i prognozy chorób neurodegeneracyjnych i neurozapalnych PL3685167T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102017000105483A IT201700105483A1 (it) 2017-09-21 2017-09-21 Metodo per la diagnosi e la prognosi di patologie neurodegenerative e neuroinfiammatorie
EP18789217.9A EP3685167B1 (en) 2017-09-21 2018-09-20 Method for the diagnosis and prognosis of neurodegenerative and neuroinflammatory diseases
PCT/IB2018/057261 WO2019058303A1 (en) 2017-09-21 2018-09-20 DIAGNOSTIC AND PROGNOSTIC METHODS FOR NEURODEGENERATIVE AND NEUROINFLAMMATORY DISEASES

Publications (1)

Publication Number Publication Date
PL3685167T3 true PL3685167T3 (pl) 2022-03-07

Family

ID=61024877

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18789217T PL3685167T3 (pl) 2017-09-21 2018-09-20 Sposób diagnozy i prognozy chorób neurodegeneracyjnych i neurozapalnych

Country Status (8)

Country Link
US (1) US11359243B2 (pl)
EP (1) EP3685167B1 (pl)
CN (1) CN111279196B (pl)
CA (1) CA3076316A1 (pl)
ES (1) ES2905144T3 (pl)
IT (1) IT201700105483A1 (pl)
PL (1) PL3685167T3 (pl)
WO (1) WO2019058303A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4067906A4 (en) * 2019-11-29 2023-04-26 FUJIFILM Wako Pure Chemical Corporation METHOD FOR AIDING THE DIAGNOSIS OF ALZHEIMER'S DISEASE OR A MILD COGNITIVE DISORDER, BIOMARKER, KIT OF REAGENTS AND DEVICE
WO2023280294A1 (zh) * 2021-07-08 2023-01-12 北京干细胞与再生医学研究院 用于治疗神经退行性疾病或中枢神经系统损伤的靶点及小分子化合物
WO2023232108A1 (zh) * 2022-06-02 2023-12-07 浙江大学医学院附属第一医院 诊断及鉴别诊断非阿尔兹海默病认知障碍的方法、系统、组合物和试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020165349A1 (en) * 2000-08-04 2002-11-07 Kirsch Wolff M. Iron regulating protein -2 (IRP-2) as a diagnostic for neurodegenerative disease
EP3060913A4 (en) * 2013-10-24 2018-04-18 Nanosomix Inc. Biomarkers and diagnostic methods for alzheimer's disease and other neurodegenerative disorders

Also Published As

Publication number Publication date
CN111279196A (zh) 2020-06-12
IT201700105483A1 (it) 2019-03-21
US20200216902A1 (en) 2020-07-09
EP3685167B1 (en) 2021-11-10
WO2019058303A1 (en) 2019-03-28
CN111279196B (zh) 2023-07-14
ES2905144T3 (es) 2022-04-07
EP3685167A1 (en) 2020-07-29
US11359243B2 (en) 2022-06-14
CA3076316A1 (en) 2019-03-28

Similar Documents

Publication Publication Date Title
SG11202001633UA (en) Diagnosis assistance system and control method therefor
ZA201803907B (en) System and method of determining the health & gender of a chick
IL272274A (en) Antibodies 4H-7B methods for their use
IL276893A (en) Systems and methods for detecting residual disease
GB201715362D0 (en) Systems and methods for automated evaluation of human speech
IL256685B (en) An isolated tau-binding antibody and its use in the treatment and diagnosis of tauopathy
GB201813459D0 (en) Transaction system and method of operation thereof
EP3117180A4 (en) Real-time digitally enhanced imaging for the prediction, application, and inspection of coatings
GB201718238D0 (en) Method and system for determining the disease status of a subject
GB2567750B (en) System and method for sensing tissue deformation
IL266106A (en) Monoclonal antibody and method of use for treatment of lupus
PL3685167T3 (pl) Sposób diagnozy i prognozy chorób neurodegeneracyjnych i neurozapalnych
HUE062956T2 (hu) Eljárások niraparib és köztitermékei elõállítására
EP3430406B8 (en) Method for cancer diagnosis and prognosis
EP3734277A4 (en) PROCESS FOR EVALUATING A MEDICINAL PRODUCT
GB201818741D0 (en) Diagnostic system and method
EP3283457A4 (en) Compounds and methods for the treatment of neurodegenerative diseases
EP3233316A4 (en) Method and system for varying the gage of metal strips
EP3576611A4 (en) SYSTEM AND METHOD FOR REMOTE DIAGNOSIS OF DISEASE EVOLUTION
HK1246271A1 (zh) 用於合成羥基-三甘油酯的方法及其用於預防和治療疾病的用途
SG11201704642WA (en) Method for the detection of hormone sensitive disease progression
IL272837A (en) A process for preparing tubolysins and their intermediates
EP3229020A4 (en) In-vitro method and kit for diagnosing the risk of suffering from caries
GB201500875D0 (en) Antibodies for treatment and diagnosis
RS63600B1 (sr) Postupci za dijagnostikovanje aneurizme ili kancera